Document is current
Any future updates will be listed below
-
Authors
Liu, Tao
Zuo, Xiaofeng
Sun, Shijie
Du, Kailong
Tao, Chuntao
Xia, Xing
Yu, Linli
Zhang, Chunxue
Yang, Zhengmei
Wang, Yitao
Ye, Junhong https://orcid.org/0000-0003-1501-0263
Bu, Youquan https://orcid.org/0000-0002-0833-0640
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81672301, 82372630, 82403031)
Natural Science Foundation of Chongqing (CSTB2023NSCQ-BHX0098)
- License Information
-
More Information
Article History
Received: 29 April 2025
Revised: 9 September 2025
Accepted: 13 October 2025
First Online: 27 November 2025
Competing interests
: The authors declare no competing interests.
: The animal study was approved by Institutional Animal Care and Use of Chongqing Medical University (IACUC-CQMU) (approval no.: IACUC-CQMU-2023-0471). Ethical approval was not required for the studies on humans because the human cancer datasets used in this study were obtained from public databases of The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). The cell lines used in this study were all commercially available. The studies were conducted in accordance with the local legislation and institutional requirements.
